Skip to content
therapeutic targets
Migraines
Chronic Pain
Asthma
PAR-2 Technology
Our Team
Contact Us
Investors
therapeutic targets
Migraines
Chronic Pain
Asthma
PAR-2 Technology
Our Team
Contact Us
Investors
Contact Us
Our treatment can have life-changing implications for patients with chronic disease, and we are looking for investors to help bring our small molecule treatment to the market.
Contact Us
Name
*
Email
*
Message
*
+
If you are human, leave this field blank.